Research is advancing faster than ever before, driving new breakthroughs in early detection, drug development, and precision medicine; giving patients the best chance for survival and quality of life. The Lustgarten Foundation is fueling the research at the center of these transformational developments.
We believe progress is paramount for improving patient outcomes, and with 59 active research grants across 30 institutions, we are poised to usher in an era of the most impactful change in history in the understanding, detection, and treatment of pancreatic cancer. We are at the forefront of advancing the best science to transform pancreatic cancer into a curable disease, dedicated to prioritizing funding of projects with the highest likelihood of accelerating progress in early detection, new drug development, and personalized medicine.